Wellgistics Health (WGRX) Announces CEO Change

Wellgistics Health, Inc. (NASDAQ: WGRX) today announced that Tim Canning, Chief Executive Officer, will be departing the company. Mr. Canning’s leadership tenure helped guide Wellgistics Health through pivotal phases, and the Company expresses gratitude for his contributions.

Brian Norton has been officially appointed as Chief Executive Officer. Mr. Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition. His ability to align on business strategy with operational execution has been instrumental in transforming organizations into industry leaders. His leadership comes at a pivotal time as the Company continues to streamline operations, expand market reach, and position itself as the industry’s most advanced and efficient vertically integrated pharmaceutical supply chain solution.

“The past year has been pivotal for Wellgistics Health, and I am proud of the work we have done in unifying multiple organizations, integrating key technologies, and laying the foundation for a scalable platform that supports pharmacies and patients across the U.S.,” said Tim Canning. “Bringing the Company through its IPO was a significant milestone, and I have great confidence in the team to build on this momentum and drive Wellgistics Health into its next phase of growth.”

The Wellgistics Health Board of Directors expressed appreciation for Mr. Canning’s leadership, particularly his role in navigating the Company’s expansion including acquisitions of the Tech & Hub, Pharmacy and Distribution business units, and strategic realignment initiatives.

“We thank Tim for his dedication to Wellgistics Health,” said Suren Ajjarapu, Chairman of the Board. “His contributions have helped lay a foundation for long-term success. Moving forward, we are confident that Brian Norton’s leadership, experience, and vision will drive the Company’s next phase of operational excellence and innovation.”

“I am honored to step into the role of CEO at such a crucial moment,” said Brian Norton. “Wellgistics Health is uniquely positioned to lead the transformation of how prescription drugs are distributed and dispensed. We are creating a tech-driven, vertically integrated supply chain that enables direct manufacturer-to-patient access. By eliminating intermediaries, enhancing transparency, and reducing costs, we are reshaping the industry and delivering long-term value for all constituents in the healthcare ecosystem along with our shareholders.”

Under Mr. Norton’s leadership, Wellgistics Health will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities.

You May Also Be Interested In

• Electra Therapeutics files for proposed IPO
• BiomX announces 1-for-10 reverse stock split effective Sept. 9
• Hyatt Hotels (H) files mixed shelf